ArticleEndocrine2019

The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancer.

Fernando Jerkovich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.